Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01944696
Other study ID # HSC-MS-13-0406
Secondary ID
Status Recruiting
Phase N/A
First received September 12, 2013
Last updated June 15, 2016
Start date March 2014
Est. completion date January 2018

Study information

Verified date June 2016
Source The University of Texas Health Science Center, Houston
Contact Jon E Tyson, MD
Phone 713-500-5651
Email jon.e.tyson@uth.tmc.edu
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Cycled (intermittent) phototherapy will be compared to continuous (uninterrupted) phototherapy in the treatment of hyperbilirubinemia (newborn jaundice) in extremely low birth weight newborns in a pilot randomized controlled trial.

Hypothesis: Cycled phototherapy (PT) will provide the same benefits as continuous phototherapy in extremely low birth weight (ELBW) infants without the risks that have been associated with continuous phototherapy.


Description:

Phototherapy (PT) is widely used and assumed to be safe as well as effective in reducing total bilirubin (TB) levels. Our recent NICHD Network Trial showed that aggressive use of phototherapy reduces neurodevelopmental impairment (NDI), but may increase deaths among ELBW infants. Among ventilator treated infants <750 g birth weight (BW) (n =696), conservative Bayesian analyses (using a neutral prior probability) identified a 99% (posterior) probability that aggressive phototherapy reduced profound NDI but a 99% probability that it increased deaths relative to conservative phototherapy. The possibility that PT increases deaths among high risk infants is also suggested by the Collaborative Phototherapy trial (performed in the 1970s), the only large RCT in which LBW infants were randomly assigned to receive PT or no PT. The relative risk for death among those randomized to PT relative to those randomized to no PT was 1.32 (0.9-1.82) among all LBW infants and 1.49 (0.93-2.40) among ELBW infants. These findings are consistent with a major increase in mortality but have been ignored because the p was >0.05, an error often made in ignoring important potential treatment hazards when power is limited.

Multiple studies, most performed decades ago in larger infants, found that short on/off cycles of PT (e.g. 15 min on/60 min off, 1 h on/3 h off, or 1 h on/1 h off ) are as effective as uninterrupted PT to reduce TSB. (Cycles with >6 h off PT do not appear to be as effective as uninterrupted PT). The clinical use of uninterrupted rather than cycled PT appears to be based largely on the assumption that PT is safe for all infants.


Recruitment information / eligibility

Status Recruiting
Enrollment 210
Est. completion date January 2018
Est. primary completion date January 2017
Accepts healthy volunteers No
Gender Both
Age group N/A to 24 Hours
Eligibility Inclusion Criteria:

- birth weight 401-1000 grams

- age less than or equal to 24 hours

Exclusion Criteria:

- hemolytic disease

- major anomaly

- overt nonbacterial infection

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Intervention

Other:
phototherapy
Cycled versus continuous phototherapy during the first 2 wks after birth, both administered at bilirubin thresholds used in the NICHD Neonatal Network Phototherapy trial .

Locations

Country Name City State
United States University of Alabama at Birmingham School of Medicine - UAB Hospital Birmingham Alabama
United States University of Cincinnati College of Medicine - Good Samaritan Hospital Cincinnati Ohio
United States The University of Texas Southwestern Medical School - Clements University Hospital Dallas Texas
United States The University of Texas Health Science Center at Houston; Memorial Hermann-TMC-NICU Houston Texas
United States Stanford University - Lucile Packard Children's Hospital Palo Alto California
United States The University of Texas Health Science Center at San Antonio - University Hospital San Antonio Texas

Sponsors (3)

Lead Sponsor Collaborator
The University of Texas Health Science Center, Houston Lucile Packard Children's Hospital, Stanford University

Country where clinical trial is conducted

United States, 

References & Publications (2)

Hintz SR, Stevenson DK, Yao Q, Wong RJ, Das A, Van Meurs KP, Morris BH, Tyson JE, Oh W, Poole WK, Phelps DL, McDavid GE, Grisby C, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Is phototherapy exposure associated with better or worse outcomes in 501- to 1000-g-birth-weight infants? Acta Paediatr. 2011 Jul;100(7):960-5. doi: 10.1111/j.1651-2227.2011.02175.x. Epub 2011 Feb 25. — View Citation

Tyson JE, Pedroza C, Langer J, Green C, Morris B, Stevenson D, Van Meurs KP, Oh W, Phelps D, O'Shea M, McDavid GE, Grisby C, Higgins R; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns? J Perinatol. 2012 Sep;32(9):677-84. doi: 10.1038/jp.2012.64. Epub 2012 May 31. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Neurodevelopmental status The Network supports and assures carefully standardized neurodevelopmental testing at 2 years adjusted age for inborn ELBW patients. The reliability of these exams is verified annually in the Network. These assessments will provide data for survival rates without impairment 2 years adjusted age Yes
Other Survival The Neonatal Research Network supports and assures outcome assessment at 2 years adjusted age for inborn ELBW patients. These assessments will provide data for survival rates and survival rates without impairment Before discharge from the neonatal ICU and at 2 years adjusted age Yes
Primary Brain stem auditory evoked response wave V latency a measure of transient or permanent bilirubin neurotoxicity 35 wks postmenstrual age or discharge Yes
Secondary Peak Total Serum Bilirubin (tsb) Total serum bilirubin (TSB) measurements will be obtained following a study protocol modeled on standard practice for monitoring TSB in ELBW newborns. 14 days from birth Yes
See also
  Status Clinical Trial Phase
Completed NCT00383318 - Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia N/A
Completed NCT00360204 - Improving Health Outcomes for New Mothers and Babies Phase 3
Completed NCT00115544 - Safety and Pharmacology of Stanate Phase 2
Completed NCT01622699 - Implementation of a Transcutaneous Bilirubinometer N/A
Terminated NCT00741117 - Conjugated Hyperbilirubinemia and Pulse Oximetry N/A
Completed NCT00288600 - Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease Phase 4
Completed NCT02774434 - Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age N/A
Completed NCT01550627 - Effect of Intravenous Fluid Supplementation on Serum Bilirubin and Cardiorespiratory Parameters in Preterm Infants During Phototherapy Phase 0
Completed NCT00653874 - Transcutaneous Bilirubinometry in Healthy Term and Near-Term Neonates Phase 3
Recruiting NCT03564678 - Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia Phase 2
Recruiting NCT04897113 - Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old N/A
Completed NCT00635375 - Comparative Study of Phototherapy for Hyperbilirubinemia N/A
Completed NCT03195998 - Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants
Terminated NCT02685189 - Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W)
Completed NCT02446951 - Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
Terminated NCT01136577 - Light-emitting Diodes (LED) Phototherapy for Hyperbilirubinemia of Term Newborn N/A
Completed NCT04271098 - The Investigation of the Causes of Hepatic Dysfunction in the Postoperative Period During Open-heart Surgeries
Completed NCT02691156 - Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants
Completed NCT00004382 - Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns Phase 2
Completed NCT00004381 - Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia Phase 2